COP-01/20

About COBIK

COBIK is a European biotech firm with a dual business model combining contract services with proprietary therapeutic development. Its service arm offers expertise in bioprocess development, scale-up, non-GMP manufacturing of biologics (pDNA, proteins, VLPs, viruses), and project management for international consortia. The company's internal pipeline targets antibiotic-resistant infections and emerging viral diseases through phage therapy and vaccine candidates, currently in pre-clinical stages. COBIK has also demonstrated an ability to spin out ventures, as seen with Sferogen (vaccines) and Tech4Meat (cultured meat).

Therapeutic Areas